title: A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus.
abstract: Ibuprofen (IBU) has previously been shown to be as effective as indomethacin (INDO) in closing the patent ductus arteriosus (PDA) of preterm infants, without severely affecting renal hemodynamics or basal cerebral blood flow. We conducted a meta-analysis of randomized trials to compare the efficacy and safety of IBU and INDO for treatment of PDA. Data from the nine relevant trials ( n =566), showed no significant difference in the efficacy of IBU and INDO in PDA closure ( P =0.70). However, five trials ( n =443) provided serum creatinine concentration data that revealed a significantly lower increase favoring IBU ( P < 0.001), and urine output data that showed a significantly lower decrease favoring IBU ( P < 0.001). In two trials ( n =188) the proportion of infants who required postnatal oxygen therapy at 28 days (defined as chronic lung disease) was significantly higher with IBU (52/94; 55.3%) than with INDO (38/94; 40.4%, P < 0.05). No statistically significant differences were found in mortality, intraventricular hemorrhage, necrotizing enterocolitis, surgical ligation, sepsis, retinopathy of prematurity, periventricular leukomalacia, length of hospital stay, gastrointestinal bleeding, re-opening of PDA, back-up treatment, surfactant therapy, or days on a ventilator.
  
  
  CONCLUSIONS
  ibuprofen and indomethacin have similar efficacy in patent ductus arteriosus closure, but preterm infants treated with ibuprofen experience lower serum creatinine values, higher urine output, and less undesirable decreased organ blood flow and vasoconstrictive adverse effects.
authors.affiliation: Children's Research Center of Michigan, Children's Hospital of Michigan, 3901 Beaubien Blvd, 48201 Detroit, Michigan, USA. Rthomas@med.wayne.edu
authors.forename: Ronald L
authors.initials: RL
authors.lastname: Thomas
authors.forename: Graham C
authors.initials: GC
authors.lastname: Parker
authors.forename: Bart
authors.initials: B
authors.lastname: Van Overmeire
authors.forename: Jacob V
authors.initials: JV
authors.lastname: Aranda
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy*; D006801:Humans; D007052:Ibuprofen / Q000627:therapeutic use*; D007213:Indomethacin / Q000627:therapeutic use*; D007231:Infant, Newborn; D007234:Infant, Premature; D010102:Oxygen Inhalation Therapy / Q000706:statistics & numerical data; D016032:Randomized Controlled Trials as Topic; D014554:Urination
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D003404:Creatinine; D007052:Ibuprofen; D007213:Indomethacin
references.citation: Ann Surg. 1996 Sep;224(3):350-5; discussion 355-7
references.pmid: 8813263
references.citation: Eur J Pediatr. 2000 May;159(5):364-8
references.pmid: 10834523
references.citation: Pediatr Res. 1991 Jul;30(1):106-11
references.pmid: 1891274
references.citation: N Engl J Med. 2000 Sep 7;343(10):674-81
references.pmid: 10974130
references.citation: Pediatr Int. 2003 Dec;45(6):665-70
references.pmid: 14651538
references.citation: Pediatrics. 2000 Mar;105(3 Pt 1):485-91
references.pmid: 10699097
references.citation: Cochrane Database Syst Rev. 2000;(2):CD000174
references.pmid: 10796168
references.citation: J Pediatr. 1983 Jun;102(6):895-906
references.pmid: 6343572
references.citation: J Pediatr. 2004 Mar;144(3):386-8
references.pmid: 15001951
references.citation: Pediatr Clin North Am. 1986 Jun;33(3):545-60
references.pmid: 3520463
references.citation: Lancet. 1995 Jul 22;346(8969):255
references.pmid: 7616831
references.citation: N Engl J Med. 2001 Jun 28;344(26):1966-72
references.pmid: 11430325
references.citation: Cochrane Database Syst Rev. 2003;(2):CD003481
references.pmid: 12804469
references.citation: Dev Pharmacol Ther. 1990;14(1):1-14
references.pmid: 2311475
references.citation: Pediatrics. 1994 Apr;93(4):543-50
references.pmid: 8134206
references.citation: JAMA. 2003 Mar 5;289(9):1124-9
references.pmid: 12622582
references.citation: JAMA. 1996 Feb 21;275(7):539-44
references.pmid: 8606475
references.citation: Pediatr Res. 2000 Jan;47(1):36-42
references.pmid: 10625080
references.citation: J Pediatr. 1978 Oct;93(4):647-51
references.pmid: 702245
references.citation: J Pediatr. 1999 Dec;135(6):733-8
references.pmid: 10586177
references.citation: J Perinatol. 2002 Oct-Nov;22(7):535-40
references.pmid: 12368968
references.citation: Eur J Pediatr. 2002 Apr;161(4):202-7
references.pmid: 12014386
references.citation: Biol Neonate. 1988;54(5):254-62
references.pmid: 3203119
references.citation: J Pediatr. 1997 Oct;131(4):549-54
references.pmid: 9386657
references.citation: Pediatrics. 1996 Oct;98 (4 Pt 1):714-8
references.pmid: 8885951
references.citation: Pediatrics. 2003 Apr;111(4 Pt 1):e340-6
references.pmid: 12671149
references.citation: Arch Dis Child Fetal Neonatal Ed. 1997 May;76(3):F179-84
references.pmid: 9175948